Analog Century Management LP Increases Position in Axon Enterprise, Inc $AXON

Key Points

• Analog Century Management LP increased its shares in Axon Enterprise by 12.1%, acquiring an additional 11,626 shares this quarter, raising its total holdings to 107,991 shares valued at approximately $56.8 million.
• Axon Enterprise's quarterly earnings exceeded expectations with an earnings per share of $2.12, beating analyst estimates of $1.54, and the company reported a 32.6% year-over-year revenue increase.
• Thirteen analysts give Axon a Buy rating, with a consensus target price of $837.69, indicating strong investor confidence in the company's future performance.

Analog Century Management LP grew its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 12.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 107,991 shares of the biotechnology company's stock after acquiring an additional 11,626 shares during the quarter. Axon Enterprise comprises approximately 4.6% of Analog Century Management LP's holdings, making the stock its 11th largest holding. Analog Century Management LP owned 0.14% of Axon Enterprise worth $56,798,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock valued at $4,540,005,000 after purchasing an additional 185,571 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in shares of Axon Enterprise by 29.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after buying an additional 212,931 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after buying an additional 763,431 shares during the last quarter. Northern Trust Corp raised its position in shares of Axon Enterprise by 1.2% during the 1st quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company's stock valued at $381,692,000 after buying an additional 8,794 shares in the last quarter. Finally, Jennison Associates LLC lifted its position in Axon Enterprise by 23,203.7% in the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock worth $322,961,000 after buying an additional 611,418 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Trading Down 4.4%

AXON traded down $34.61 on Monday, reaching $747.29. 583,191 shares of the company traded hands, compared to its average volume of 710,848. The company has a market cap of $58.66 billion, a P/E ratio of 184.52, a price-to-earnings-growth ratio of 27.43 and a beta of 1.40. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a one year low of $346.71 and a one year high of $885.91. The firm has a fifty day simple moving average of $772.14 and a two-hundred day simple moving average of $677.30.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. During the same period last year, the company posted $1.20 earnings per share. The company's quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, Director Hadi Partovi purchased 1,358 shares of the business's stock in a transaction dated Wednesday, August 13th. The shares were purchased at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the purchase, the director owned 237,938 shares in the company, valued at approximately $176,074,120. This represents a 0.57% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the company's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the sale, the insider directly owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. This trade represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 40,790 shares of company stock worth $31,432,171 over the last quarter. Insiders own 5.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Wolfe Research began coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They set an "outperform" rating on the stock. Bank of America lifted their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Barclays increased their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. JPMorgan Chase & Co. raised their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday, July 17th. Finally, Craig Hallum upgraded Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 target price for the company in a research report on Tuesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $837.69.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.